The Research and Development team at Interline Therapeutics focuses on advancing the understanding of molecular mechanisms underlying inflammation and cancer. This multidisciplinary group collaborates to design and test novel therapeutic candidates, utilizing expertise in human genetics, protein dynamics, and cheminformatics to drive innovative drug discovery and development efforts.
Brenda Schulman
Founding Scientific Advisor
Emma Lundberg
Scientific Advisor
Hsiang-Ching Chung
Scientist
John Chodera
Founding Scientific Advisor
John Klimek
Scientist Proteomics
Lyn Jones
Scientific Advisor
Mike Varney
Director & Founding Scientific...
Mohammed Alquraishi
Scientific Advisor
Nevan Krogan
Founding Scientific Advisor
Wade Harper
Founding Scientific Advisor
View all